Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page
If You Invested $100 In Jones Lang LaSalle Stock 20 Years Ago, You Would Have This Much Today

If You Invested $100 In Jones Lang LaSalle Stock 20 Years Ago, You Would Have This Much Today

by Benzinga Insights | Dec 16, 2025 | General

Jones Lang LaSalle (NYSE:JLL) has outperformed the market over the past 20 years by 1.07% on an annualized basis producing an average annual return of 9.8%. Currently, Jones Lang LaSalle has a market capitalization of $15.53 billion. Buying $100 In JLL: If an investor...
Why Bitcoin Down 3% Since The Fed Cut Rates Again?

Why Bitcoin Down 3% Since The Fed Cut Rates Again?

by Parshwa Turakhiya | Dec 16, 2025 | General

Bitcoin (CRYPTO: BTC) is down 3% over the past week, dashing expectations that the Federal Reserve’s rate cut the week prior would spark a relief rally. Fed Eases Policy But Signals Caution According to Wintermute’s latest market update, the rate cut, which came with...

Jobs Data Leaves Economists Split — Is Labor Market Just Cooling Or Cracking?

by Piero Cingari | Dec 16, 2025 | General

November’s delayed jobs report failed to deliver the clarity investors were looking for. Instead, it widened the divide among Wall Street economists debating whether the U.S. labor market is simply cooling or quietly starting to crack. At the center of the...

Peruvian Cement Stock Cementos Pacasmayo Skyrockets After Holcim Move

by Akanksha Bakshi | Dec 16, 2025 | General

Cementos Pacasmayo S.A.A. (NYSE:CPAC) stock skyrocketed Tuesday after the company announced a significant ownership change after a global cement leader agreed to acquire its controlling shareholder. Switzerland-based Holcim Ltd. (OTC:HCMLY) signed an agreement to...

Nektar Alopecia Trial Misses Endpoint, Hits Significance After Patient Exclusion

by Vandana Singh | Dec 16, 2025 | General

Nektar Therapeutics (NASDAQ:NKTR) on Tuesday revealed topline results from the 36-week induction treatment period of the Phase 2b REZOLVE-AA trial of investigational rezpegaldesleukin. The global Phase 2b study is being conducted in 92 patients with...
« Older Entries
Next Entries »

Recent Posts

  • A Look Into Micron Technology Inc’s Price Over Earnings
  • If You Invested $100 In CBRE Group Stock 5 Years Ago, You Would Have This Much Today
  • Bitcoin To Make New Highs In 2026 As Cycle Theory Breaks, Grayscale Says
  • Robotics ETFs Or EV ETFs: The Safer Bet For 2026?
  • Is Tilray Stock Headed To New Highs? What You Need To Know

Recent Comments

    Archives

    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.